Biochemical Reagent
- BA5856 AcazicolceptSummary: Azacicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell co-stimulator/antagonist.
- BA5857 CD80-IN-3Summary: CD80-IN-3 is a potent inhibitor.
- BA5858 SolitomabSummary: Solitomab (AMG110) is a bispecific anti- and anti-epithelial cell adhesion molecule antibody.
- BA5859 MuromonabSummary: Muromonab is a monoclonal antibody that targets the receptor.
- BA5860 CibisatamabSummary: Cibisatamab (CEA-TCB) is a T-cell bispecific antibody that binds to carcinoembryonic antigen on cancer cells and on T cells.
- BA5861 ObrindatamabSummary: Obrindatamab is a humanized anti-bispecific antibody.
- BA5862 PavurutamabSummary: Pavurutamab (AMG-701) is a bispecific T-cell splicer molecule against and anti-B-cell maturation antigen.
- BA5863 PacanalotamabSummary: Pacanalotamab (AMG420; BI-836909) is a bispecific T cell engager (BiTE).
- BA5864 PasotuxizumabSummary: Pasotuxizumab (BAY2010112) is a bispecific T-cell engager (BiTE).
- BA5865 VoxalatamabSummary: Voxalatamab (JNJ-63898081) is a conjugateable bispecific antibody.